Company · CIK 1873093
CytoMed Therapeutics Ltd
| CIK | 1873093 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | U0 |
| Business address | Singapore |
| Listed | GDTC (Nasdaq) |
| First annual or quarterly report | 2023-05-01 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-288033 | 2025-06-13 | 2025-08-18 | 3 | |
| 333-268456 | 2022-11-18 | 2023-04-17 | 8 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2025-08-18 | 424B5Shelf takedown | 333-288033 | 0001641172-25-024608 |
| 2025-06-23 | EFFECTDeclared effective | 333-288033 | 9999999995-25-001998 |
| 2025-06-13 | F-3Shelf registered | 333-288033 | 0001641172-25-015075 |
| 2023-04-17 | 424B4Final prospectus | 333-268456 | 0001493152-23-012534 |
| 2023-03-31 | EFFECTDeclared effective | 333-268456 | 9999999995-23-000774 |
| 2023-03-30 | F-1/AAmendment | 333-268456 | 0001493152-23-009652 |
| 2023-03-28 | F-1/AAmendment | 333-268456 | 0001493152-23-009156 |
| 2023-03-16 | F-1/AAmendment | 333-268456 | 0001493152-23-007810 |
| 2023-02-21 | F-1/AAmendment | 333-268456 | 0001493152-23-005626 |
| 2023-02-01 | F-1/AAmendment | 333-268456 | 0001493152-23-003198 |
| 2022-11-18 | F-1Registration filed | 333-268456 | 0001493152-22-032838 |
| 2021-09-28 | DRSDraft made public | 377-05542 | 0001493152-21-024011 |